Outlook on the Dental Bone Graft Substitutes Global Market to 2026 - Featuring Dentsply Sirona, Medtronic and Collagen Matrix Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Dental Bone Graft Substitutes Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

The Dental Bone Graft Substitutes market is expected to grow with an estimated CAGR of 6.8%, over the forecast period.

Companies Mentioned

• Dentsply Sirona
• Johnson & Johnson
• Institut Straumann AG
• Medtronic PLC
• ZIMMER BIOMET
• Geistlich Pharm
• Dentium
• LifeNet Health
• Collagen Matrix Inc.
• Halma plc (Novabone LLC)
• Botiss biomaterials GmbH
• Wright Medical Group N.V.

Key Market Trends

The Xenogaft Segment is Expected to Grow Over the Forecast Period

A xenograft is an organ transplant or a tissue graft to an individual of other species. Xenografts are obtained from pigs (porcine) or cows (bovine). Xenografts are prepared for implantation into the human body once they are thoroughly cleaned and sterilized. Deproteinized bovine bone is the most common source of xenograft materials in the field of dentistry. Studies have found that 39% of new bone formation after 6 months of duration has been observed with maxillary sinus defect sites grafted with BioOss, whereas following the grafting with autograft it is reported that 40% of new bone formation takes place in the same duration of time.

Few of the commercially available xenografts are Bio-Oss, Bio - Oss Collagen, Pepgen - P15, etc. As xenograft is most affordable, the key players in the market are taking initiatives to launch new products into the market. For instance, BioHorizons has launched MinerOss X, xenograft products for the development of dental implant procedures, which is designed for sinus augmentation, ridge augmentation, grafting for implant placements, and for extraction of sockets. Hence, these factors will drive the segment growth in the future.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America holds the major market share in the dental bone graft substitute market. According to the Centers for Disease Control and Prevention around 64.9% of adults aged 18 and above had dental visits in the year 2019 in the United States. A United States company Dentsply Sirona announced that it has acquired Datum Dental, Ltd, which is known for innovative dental regeneration products on January 2021. Dentsply Sirona and Datum Dental Ltd, were already in distribution agreement since 2016, with this acquisition Dentsply Sirona is promoting the full OSSIX portfolio (OSSIX Plus, OSSIX Volumax, and OSSIX Bone) in the U.S., Canada, and several other countries.

As per Canada, health fact sheets, in 2018 around 74.7% of Canadians have visited dentists, almost 2/3rd Canadians (64.6%) have dental insurance to cover their expenses. Though general oral health care is not included in the Canada health act, they have several government programs to look into dental issues such as dental coverage.These factors strongly pave the path for the dental bone graft substitutes market positively.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Incidence of Cancer

4.2.2 Growing Geriatic Population

4.2.3 Increasing Research and Development Activities for the Development of Novel Therapeutics

4.3 Market Restraints

4.3.1 Stringent Government Regulations

4.3.2 High Manufacturing Costs of Antibody Drug Conjugates

4.4 Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Product Type

5.2 By Application

5.3 By Technology

5.4 By Target Type

5.5 By End Users

5.6 Geography

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/1lj9i5